OQROGet OQRO Pro
Insider trade

Newamsterdam Pharma Co N.V. (NAMS)Chief Accounting Officer sold ~$1.34M

Louise Frederika Kooij, Chief Accounting Officer at Newamsterdam Pharma Co N.V., sold ~$1.34M of Newamsterdam Pharma Co N.V. shares.

~$1.34M
Approx. value · 53K sh @ $25.31
112K
Holds after · shares reported
Traded
Sep 9, 2025
Filed
Sep 10, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 15, 2025Insider · 1 personInsiders: 2 sales (~$1.0M)
  2. Jul 16, 2025InsiderOfficer sold ~$1.08M of NAMS shares in the open market
  3. Aug 11, 2025InsiderDirector purchased ~$11K of NAMS shares in the open market
  4. Aug 21, 2025InsiderDirector sold ~$1.21M of NAMS shares in the open market
  5. Aug 22, 2025Insider · 1 personInsiders: 2 sales (~$1.3M)
  6. Aug 25, 2025InsiderOfficer sold ~$206K of NAMS shares in the open market
  7. Sep 3, 2025InsiderOfficer sold ~$453K of NAMS shares in the open market
  8. Sep 8, 2025InsiderDirector purchased ~$31K of NAMS shares in the open market
  9. Sep 9, 2025 · this disclosureInsiderOfficer sold ~$1.34M of NAMS shares in the open market

What came next

  1. Sep 9, 2025InsiderOfficer sold ~$2.53M of NAMS shares in the open market
  2. Sep 15, 2025InsiderDirector purchased ~$16K of NAMS shares in the open market
  3. Nov 5, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Newamsterdam Pharma Co N.V.

For Newamsterdam Pharma Co N.V., OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 6 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NAMS page.

Other recent filings by Louise Frederika Kooij, Chief Accounting Officer

The full history of Louise Frederika Kooij, Chief Accounting Officer is on the profile page.

How this filing works

Other disclosures at Newamsterdam Pharma Co N.V.

Everything OQRO holds on this company is on its NAMS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data